| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 24 | 2024 | 466 | 5.160 |
Why?
|
| Muscular Dystrophy, Duchenne | 9 | 2024 | 33 | 2.880 |
Why?
|
| Annexin A6 | 6 | 2022 | 10 | 2.270 |
Why?
|
| Muscular Dystrophies | 7 | 2024 | 55 | 2.140 |
Why?
|
| Muscle Proteins | 8 | 2021 | 133 | 2.120 |
Why?
|
| Cell Membrane | 9 | 2021 | 668 | 2.020 |
Why?
|
| Membrane Proteins | 11 | 2021 | 1215 | 1.980 |
Why?
|
| Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.870 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 48 | 1.810 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 464 | 1.760 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 5 | 2024 | 14 | 1.420 |
Why?
|
| Dysferlin | 6 | 2024 | 14 | 1.390 |
Why?
|
| Calcium | 4 | 2022 | 1172 | 1.200 |
Why?
|
| Mice, Inbred mdx | 5 | 2024 | 13 | 1.180 |
Why?
|
| Muscle Development | 6 | 2019 | 41 | 1.160 |
Why?
|
| Dried Blood Spot Testing | 3 | 2021 | 10 | 1.120 |
Why?
|
| Vesicular Transport Proteins | 3 | 2015 | 63 | 1.050 |
Why?
|
| Muscles | 3 | 2024 | 193 | 1.000 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2362 | 0.990 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 55 | 0.970 |
Why?
|
| Mice | 27 | 2024 | 11742 | 0.880 |
Why?
|
| Myoblasts | 7 | 2024 | 32 | 0.840 |
Why?
|
| Sarcolemma | 10 | 2019 | 31 | 0.830 |
Why?
|
| Sarcoglycans | 7 | 2024 | 14 | 0.830 |
Why?
|
| Animals | 36 | 2024 | 27324 | 0.810 |
Why?
|
| Membrane Fusion | 3 | 2021 | 37 | 0.810 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 31 | 0.790 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 8 | 0.790 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 313 | 0.780 |
Why?
|
| Family Characteristics | 2 | 2022 | 48 | 0.770 |
Why?
|
| Serologic Tests | 2 | 2021 | 43 | 0.770 |
Why?
|
| Annexins | 2 | 2022 | 6 | 0.770 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 115 | 0.720 |
Why?
|
| Pandemics | 5 | 2023 | 771 | 0.710 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 114 | 0.690 |
Why?
|
| Gene Editing | 1 | 2019 | 47 | 0.670 |
Why?
|
| Exons | 3 | 2019 | 451 | 0.670 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2022 | 43 | 0.660 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 309 | 0.630 |
Why?
|
| Biomarkers | 2 | 2024 | 1755 | 0.630 |
Why?
|
| Health Personnel | 1 | 2020 | 212 | 0.610 |
Why?
|
| Muscle Cells | 1 | 2017 | 18 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.580 |
Why?
|
| Protein Transport | 8 | 2016 | 421 | 0.570 |
Why?
|
| Health | 1 | 2015 | 29 | 0.520 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.500 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.500 |
Why?
|
| Disease | 1 | 2015 | 90 | 0.500 |
Why?
|
| Neutralization Tests | 4 | 2022 | 80 | 0.500 |
Why?
|
| Muscular Diseases | 3 | 2023 | 64 | 0.470 |
Why?
|
| Dynamin II | 1 | 2014 | 15 | 0.470 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 10 | 0.470 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 5 | 0.470 |
Why?
|
| Proteostasis | 2 | 2024 | 12 | 0.470 |
Why?
|
| Glycerol | 1 | 2013 | 35 | 0.450 |
Why?
|
| Glucocorticoids | 4 | 2023 | 357 | 0.440 |
Why?
|
| Actins | 1 | 2016 | 458 | 0.430 |
Why?
|
| Male | 18 | 2024 | 42254 | 0.430 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 120 | 0.420 |
Why?
|
| Fibrosis | 4 | 2023 | 234 | 0.410 |
Why?
|
| Mice, Knockout | 6 | 2024 | 1990 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3443 | 0.410 |
Why?
|
| Gene Expression | 3 | 2019 | 1310 | 0.390 |
Why?
|
| Antibody Formation | 2 | 2021 | 171 | 0.380 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 53 | 0.370 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2011 | 0.370 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 56 | 0.370 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 49 | 0.360 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.350 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.350 |
Why?
|
| DNA | 1 | 2015 | 1307 | 0.350 |
Why?
|
| Wound Healing | 4 | 2016 | 359 | 0.340 |
Why?
|
| Prednisone | 3 | 2019 | 258 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 3211 | 0.320 |
Why?
|
| Female | 14 | 2024 | 46014 | 0.320 |
Why?
|
| Humans | 28 | 2024 | 89073 | 0.310 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 244 | 0.310 |
Why?
|
| Carrier Proteins | 3 | 2021 | 681 | 0.280 |
Why?
|
| Young Adult | 4 | 2021 | 6289 | 0.260 |
Why?
|
| Vaccination | 3 | 2023 | 273 | 0.250 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2880 | 0.250 |
Why?
|
| Regeneration | 3 | 2017 | 150 | 0.250 |
Why?
|
| Immunoblotting | 2 | 2016 | 273 | 0.240 |
Why?
|
| Filamins | 1 | 2024 | 22 | 0.240 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 264 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 44 | 0.230 |
Why?
|
| Myocarditis | 1 | 2024 | 51 | 0.230 |
Why?
|
| Middle Aged | 6 | 2023 | 25865 | 0.230 |
Why?
|
| Mice, Inbred DBA | 6 | 2024 | 149 | 0.230 |
Why?
|
| Adult | 6 | 2024 | 26508 | 0.220 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 231 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 313 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 287 | 0.210 |
Why?
|
| Tissue Engineering | 1 | 2024 | 185 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1574 | 0.210 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 121 | 0.200 |
Why?
|
| Immunologic Tests | 1 | 2021 | 6 | 0.200 |
Why?
|
| Monocytes | 1 | 2023 | 218 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 511 | 0.200 |
Why?
|
| Drug Interactions | 1 | 2021 | 245 | 0.190 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 42 | 0.190 |
Why?
|
| Heart Diseases | 1 | 2023 | 298 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1521 | 0.180 |
Why?
|
| Steroids | 1 | 2021 | 174 | 0.180 |
Why?
|
| Genes, Modifier | 2 | 2017 | 5 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2024 | 429 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2021 | 284 | 0.180 |
Why?
|
| Cell Movement | 1 | 2024 | 783 | 0.180 |
Why?
|
| Chicago | 2 | 2021 | 1423 | 0.170 |
Why?
|
| Lysosomes | 2 | 2010 | 111 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 374 | 0.170 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 321 | 0.170 |
Why?
|
| MyoD Protein | 1 | 2019 | 16 | 0.170 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.170 |
Why?
|
| Signal Transduction | 1 | 2009 | 3374 | 0.160 |
Why?
|
| Point Mutation | 1 | 2019 | 245 | 0.160 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1837 | 0.160 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 123 | 0.160 |
Why?
|
| Morpholinos | 1 | 2018 | 13 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1239 | 0.160 |
Why?
|
| Dystrophin | 4 | 2024 | 22 | 0.150 |
Why?
|
| Adolescent | 2 | 2021 | 9237 | 0.150 |
Why?
|
| Phenotype | 1 | 2024 | 2439 | 0.150 |
Why?
|
| Osteopontin | 1 | 2017 | 47 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1012 | 0.150 |
Why?
|
| Protein Binding | 4 | 2022 | 1487 | 0.150 |
Why?
|
| Phospholipids | 1 | 2017 | 111 | 0.140 |
Why?
|
| Genetic Therapy | 2 | 2018 | 370 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2014 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 428 | 0.140 |
Why?
|
| Exosomes | 1 | 2017 | 53 | 0.140 |
Why?
|
| Cell Communication | 1 | 2017 | 199 | 0.130 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.130 |
Why?
|
| Electroporation | 1 | 2015 | 57 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2024 | 1652 | 0.130 |
Why?
|
| Base Sequence | 1 | 2019 | 2327 | 0.130 |
Why?
|
| Creatine Kinase | 1 | 2015 | 52 | 0.130 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 68 | 0.130 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 144 | 0.130 |
Why?
|
| Plasmids | 1 | 2015 | 291 | 0.130 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 277 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 141 | 0.120 |
Why?
|
| Heterozygote | 1 | 2015 | 373 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2335 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 243 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2015 | 426 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2021 | 2863 | 0.120 |
Why?
|
| Caveolin 3 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Cell Line | 4 | 2024 | 2495 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 921 | 0.110 |
Why?
|
| HIV Infections | 1 | 2023 | 835 | 0.110 |
Why?
|
| Aged | 2 | 2021 | 19078 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 136 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 387 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 982 | 0.110 |
Why?
|
| Endosomes | 2 | 2010 | 79 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2014 | 195 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2017 | 551 | 0.100 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 5 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1975 | 0.090 |
Why?
|
| Cardiotoxins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.090 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 3 | 0.090 |
Why?
|
| Myofibrils | 1 | 2009 | 23 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2010 | 138 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 276 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1764 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2399 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 180 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2019 | 152 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 956 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2022 | 638 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2006 | 26 | 0.070 |
Why?
|
| Annexin A2 | 1 | 2024 | 2 | 0.060 |
Why?
|
| Decorin | 1 | 2024 | 6 | 0.060 |
Why?
|
| Electrophysiological Phenomena | 1 | 2024 | 51 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2006 | 599 | 0.060 |
Why?
|
| Bortezomib | 1 | 2024 | 82 | 0.060 |
Why?
|
| Mutation | 3 | 2024 | 4132 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2024 | 136 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 197 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 607 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 229 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 41 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 726 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 102 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 230 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 22 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 91 | 0.050 |
Why?
|
| Heart | 1 | 2024 | 573 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2022 | 511 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 740 | 0.050 |
Why?
|
| Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 2019 | 9 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 306 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2019 | 42 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2019 | 1371 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 200 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 75 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 100 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1488 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 103 | 0.040 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 76 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1533 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 41 | 0.040 |
Why?
|
| Annexin A1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Urine | 1 | 2018 | 89 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 160 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 783 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 45 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 277 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 105 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 46 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 258 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 291 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 292 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 131 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 44 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 507 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 894 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 82 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 755 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2752 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 19 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1706 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 36 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 565 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 369 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 200 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2014 | 210 | 0.030 |
Why?
|
| Myocardium | 1 | 2015 | 571 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 5320 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 613 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 508 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 557 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 779 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
| Child | 1 | 2019 | 7149 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 211 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 353 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 38 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 96 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2062 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1296 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3027 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 327 | 0.010 |
Why?
|